Podcasts about Harvard Medical School

What if our loyalty is not to the healthcare system we were handed, it's to the future we can build? And how do we crack an industry highly resistant to change? In Halle Tecco's newest book, Massively Better Healthcare, Tecco offers an insider's guide to transforming healthcare through innovation. Drawing on her experience as an entrepreneur, investor, and educator, she distills 15+ years of lessons into a practical roadmap for building solutions that align profit with purpose, and a guide for leaders who want to leave the system better than they found it.rnrnHalle Tecco has dedicated her career to making healthcare massively better. She is the founder of Rock Health and has backed and advised dozens of healthcare companies. She teaches future healthcare leaders at Columbia Business School and Harvard Medical School, and serves on the boards of Collective Health and Cofertility. Tecco's work has been featured in The New York Times, The Wall Street Journal, and Bloomberg. She was named as one of Goldman Sach's Most Intriguing Entrepreneurs and listed on Fast Company's Most Creative People in Business 2023.

In this episode, we explore essential baseline testing, monitoring protocols, and optimal dosing strategies for lithium with Dr. David Osser from Harvard Medical School. Why does giving lithium once daily at night actually protect the kidneys better than divided doses? Discover evidence-based approaches that could transform your lithium prescribing practice. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: An Update on Bipolar Mania Algorithm Diagnosing Bipolar Mania and Comorbid Disorders

In this powerful conversation with David Cory, we unpack the real difference between EI and EQ — and why emotional intelligence is no longer a “soft skill,” but a leadership necessity. We explore vulnerability (and the myth of “big boys don't cry”), the idea of sharing emotions instead of wearing them, and how to “name it to tame it” rather than stuffing feelings down. David breaks down transformational vs transactional leadership, the true meaning of self-awareness and impulse control, and why your influence ultimately comes down to your self-regard, independence, and presence with empathy. Plus — one absolute gold-dust coaching question you'll want to steal: “Why won't you let me help you?” “If your emotional abilities aren't in hand, if you don't have self-awareness, if you're not able to manage your distressing emotions, then no matter how smart you are, you're not going to get very far.” — Daniel Goleman About David Cory - Founder & Leadership Development Coach David Cory is a leadership development coach, trainer, and consultant recognised for his expertise in applying emotional intelligence to improve individual and organisational performance. Since 1998, David and his team have implemented EI development programs with leaders in some of the world's most progressive organisations. He has been a keynote speaker at conferences globally, including Harvard Medical School, and is a six-time keynote speaker at the Asia HR Congress (Bahrain, Brunei, Singapore, and Kuala Lumpur twice). Most recently, he delivered a keynote at the World of Tomorrow Leadership Conference in Paradise Island, Maldives. Connect with David: Website: https://www.eitrainingcompany.com Personal LinkedIn: https://www.linkedin.com/in/emotionalintelligence/ Company LinkedIn: https://www.linkedin.com/company/the-emotional-intelligence-training-company-inc-

Health Affairs' Jeff Byers welcomes Deputy Editor Leslie Erdelack back to the pod to break down recent turbulence at the FDA following the departure of Vinay Prasad, whose decisions around rare‑disease gene therapies courted controversy. They explore the fast‑growing rare disease therapeutics market, why traditional clinical trials often don't work for ultra‑rare genetic conditions, and the new FDA draft guidance for rare disease drug development. On March 24th, join us for our upcoming Insider exclusive event focusing on pharmacy benefit manager reform with Harvard Medical School's Benjamin Rome.Become an Insider to get access to this event, trend reports, cheat sheets, and exclusive newsletters.Related Articles:FDA vaccines chief who ran afoul of pharma to depart (Politico)Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care (PR Newswire)FDA NEWS RELEASE: FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases FDA illuminates new approval pathway for bespoke gene editing therapies (Fierce Biotech)One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma (The New England Journal of Medicine)

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question.In this episode, "Key Challenges Facing Neurology in the Year Ahead," Natalia Rost, MD, President of the American Academy of Neurology (AAN), Stroke Division Chief at Massachusetts General Hospital, and Professor of Neurology at Harvard Medical School, joins NeurologyLive to discuss the top clinical priorities shaping neurology in 2026.Throughout the discussion, Rost outlines the most urgent unmet needs across neurology, including expanding equitable access to care, integrating preventive neurology into routine practice, strengthening the workforce, and closing persistent evidence gaps. She explains how the AAN Brain Health Initiative provides a practical framework for embedding brain health into everyday clinical encounters. The conversation also explores the growing role of biomarkers, imaging, and digital tools in care delivery, where innovation may be outpacing evidence, and how the Academy aims to guide ethical and evidence based implementation while addressing ongoing health equity gaps.Episode Breakdown: 1:10 – Most urgent unmet clinical needs facing neurology in 2026 3:25 – Implementing brain health in everyday clinical practice 8:00 – Role of biomarkers, imaging, and digital tools in routine neurologic care 11:20 – AAN priorities for education, advocacy, and clinical guidance in 2026 14:25 – Major clinical gaps driving health inequities in neurologic care and outcomes Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

If you've grown your business beyond a solo practice with a small team, you've likely learned the hard way that one bad hire can derail momentum, create internal chaos, and hold your entire business hostage.In this episode, I'm excited to have leadership expert, author, and HR strategist Tom Healy on the podcast. Tom has worked with high-performing organizations, including the U.S. Navy, Harvard Medical School, and Fortune 500 companies, and he's spent decades helping businesses scale the right way — with structure, accountability, and culture at the center.We unpack the mistakes founders make when hiring too fast, how poor performers slowly sabotage organizations, and the exact systems you need to have in place to prevent one person from controlling your business.3 of the biggest insights from Tom …#1.) It's Okay to Overpay for A-Players The cheapest hire is often the most expensive mistake. High performers operate like owners, stay longer, and eliminate the hidden cost of turnover. Paying above market isn't reckless, it's strategic.#2.) Poor Performers Will Hide When There's No AccountabilityIf you don't have clear KPIs, you don't have leverage. Vague feedback creates arguments. Objective metrics create clarity. A-players want coaching. B and C players resist it.#3.) No One Should Be Able to Hold Your Business HostageWhen all knowledge lives inside one person's head, you're exposed. Document systems. Build an internal knowledge center. Consider fractional talent. Structure creates freedom.SHOW NOTEShttps://bradleyjohnson.com/159FOLLOW BRAD JOHNSON ON SOCIALTwitterInstagramLinkedInFOLLOW DBDL ON SOCIAL:YouTubeTwitterInstagramLinkedInFacebookDISCLOSURE DBDL podcast episode conversations are intended to provide financial advisors with ideas, strategies, concepts and tools that could be incorporated into their business and their life. No statements made in the episode are offered as, and shall not constitute financial, investment, tax or legal advice. Financial professionals are responsible for ensuring implementation of anything discussed related to business is done so in accordance with any and all regulatory, compliance responsibilities and obligations. The Triad member statements reflect their own experience which may not be representative of all Triad Member experiences, and their appearances were not paid for. Triad Wealth Partners, LLC is an SEC Registered Investment Adviser. Please visit Triadwealthpartners.com for more information. Triad Wealth Partners, LLC and Triad Partners, LLC are affiliated companies. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today I'm joined by Srini Pillay, a Harvard-trained psychiatrist, neuroscientist, author, and entrepreneur.Dr. Pillay is a former Assistant Professor of Psychiatry at Harvard Medical School and the CEO of NeuroBusiness Group, where he applies neuroscience to leadership, creativity, and innovation. His work focuses on how the brain shapes identity, confidence, attention, and performance.He's the author of several books, including Life Unlocked: 7 Revolutionary Lessons to Overcome Fear and Tinker Dabble Doodle Try, which explores how imagination and unfocused thinking can enhance creativity and problem-solving.We tend to think of the self as fixed.But neuroscience suggests something radical — that the ‘self' might be a construction. A prediction model. A story the brain keeps updating.So what happens if you deliberately update it?What if you step into the qualities of someone you admire — not as fantasy, but as training?Today we talk about his concept of psychological Halloweenism — and whether consciously inhabiting a different identity can change confidence, creativity, and even the body.Is this method acting? Meditation? Neural rewiring?Or something more ancient than we realize?https://drsrinipillay.com/ Hosted on Acast. See acast.com/privacy for more information.

Subscribe here or wherever you get your podcasts.Watch the video versions of our podcasts and Subscribe there as well!Today's guide is Alice Flaherty, MD, PhD neurologist at the Massachusetts General Hospital and associate professor of psychiatry and neurology at Harvard Medical School. She is the author of numerous books and studies including The Midnight Disease: The Drive to Write, Writer's Block, and the Creative Brain. Dr. Flaherty draws on neurology, the lives of writers, and her own experience to discuss both the creative and obsessive drives to write.Please rate us and leave reviews. It really helps get us to more listeners.This podcast is produced by the Northeast Region Biofeedback Society. NRBS is an organization for professionals, students, and everyone interested in neurofeedback, biofeedback, and whole body health.Learn more about Dr. Saul Rosenthal at advancedbehavioral.care.Contact us at healthybrain@nrbs.org.Our theme music is Catch It by Coma-MediaThe Healthy Brain Happy Body logo was designed by Alexandra VanDerlyke. Our heartfelt thanks to her and the rest of the team at Collectively Rooted.#biofeedback #neurofeedback #nrbs #brain #mindbodyhealth #creativity

Health Affairs' Jeff Byers welcomes Senior Editor Margaret Winchester to the pod to discuss Trump's recent State of the Union Address and unpacking its health care and health policy talking points, including most-favored nation drug pricing, health savings accounts, and if there's a path toward codification for either.On March 24th, join us for our upcoming Insider exclusive event focusing on pharmacy benefit manager reform with Harvard Medical School's Benjamin Rome.Related Articles:National Health Care Spending Increased 7.2 Percent In 2024 As Utilization Remained Elevated (Health Affairs)Trump's State of the Union trumpets healthcare greatest hits, but no new policies (Healthcare Dive)

Adam Rodman, MD, MPH, FACP, a general internis­­­t and medical educator at Beth Israel Deaconess Medical Center, where he directs AI Programs for the Carl J. Shapiro Center for Education and Research, and an assistant professor at Harvard Medical School, talks about his recent New York Times op-ed outlining best (and worst) practices for patients wanting to incorporate AI into office visits with their physicians. → Take It From a Doctor: It's OK if Your Medical Advice Comes From A.I.Photo: Stethoscope and Laptop Computer. Source: National Cancer Institute via Unsplash.

Send a textWellness is a word we hear all the time—but what does it actually mean when life is complicated, busy, and sometimes overwhelming? In this milestone 200th episode, I explore the idea that living well isn't about perfection or rigid routines, but about the small choices we make every day that quietly shape our health, our relationships, and the direction of our lives. I invite you to reflect on the emotions you're choosing from, the responsibilities you're carrying, and the possibility that wellness might be closer than you think. If you've ever wondered how to care for yourself while managing a full and demanding life, this conversation might open a new perspective on what it truly means to live well.Quotes of the Week“Well-being is realized by small steps, but is truly no small thing.” — Zeno “The part can never be well unless the whole is well.” — Plato CitationsCohen, S., Janicki-Deverts, D., & Miller, G. E. (2012). Psychological stress and disease. JAMA.Lee, I. M., et al. (2019). Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Internal Medicine.Waldinger, R., & Schulz, M. Harvard Study of Adult Development. Harvard Medical School.National Institutes of Health – Your Healthiest Self: Wellness Toolkits. Let's go, let's get it done. Get more information at: http://projectweightloss.org

Dr. Jonathan Haywood Jenkins, Psy.D., CMPC, has spent more than a decade supporting athlete mental health and performance at Massachusetts General Brigham Hospital. As a member of the Harvard Medical School teaching community, he serves as Team Clinical and Performance Psychologist for the New England Patriots, Behavioral Sport Psychologist for the Boston Red Sox, and Sport Psychology Consultant for the Para Rowing Foundation. He is also the co-author of Mentality Wins: The Athlete's Playbook for Thriving in Sport and Life, currently the #1 New Release in Sport Psychology, a holistic guide to improving performance while protecting mental health. In this episode, Dr. Jenkins shares the Peachtree Approach and the deeper principles that drive sustainable success. Drawing from his own early speech and language challenges, his experience as a collegiate athlete, and his work with elite performers, he explains how adversity can become an advantage, how relationships fuel resilience, and why appreciating the good days prepares us for the hard ones. This conversation goes beyond sport. It's about leadership, perspective, and building a mentality that lasts. @dr.jonathanjenkins, @Unlimitedresilence, @mentalitywinsbook

This time on Code WACK! Millions of Americans have health insurance, but still can't afford to use it. So what happens when high deductibles and corporate profit pressures shape the care patients receive? To break it down, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's also a former president of Physicians for a National Health Program, and his work focuses on health care financing and national reform. This is the second episode in a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

Marriage has evolved a lot through the years – and so have the problems and rewards that come with it. Research suggests it benefits our physical and mental health, but it might not seem like it when conflict arises and couples struggle to co-manage a household. With greater social acceptance of a variety of lifestyle choices, many people – especially young women – are thinking twice before tying the knot. In this episode, host Samantha Laine Perfas talks with business professor Debora Spar, psychiatrist and family counselor Richard Schwartz, and bestselling author Eve Rodsky about the role of marriage in modern society.

“We should all be able to look at the numbers and agree that this is not sustainable and that whatever we've been doing is not working. Democrats have had their chance, and Republicans have had their chance, and it's only gotten worse.” — Halle TeccoWarren Buffett called America's healthcare costs “a hungry tapeworm on the American economy.” That tapeworm now devours nearly a fifth of the nation's GDP—and the patient, as always, is on the table. We dedicate today's show to this most perennial of all America's problems, with two guests and two new books that approach the tragi-comedy from different angles.Self-styled innovation wonk Halle Tecco—founder of Rock Health, investor in over fifty digital health companies, professor at Columbia Business School—argues in Massively Better Healthcare that the system is both excessively public and excessively private, a Kafkaesque bureaucracy in which verticalized health plans now own the PBMs, the pharmacies, and increasingly the doctors. The result is monopoly medicine on a scale that would have appalled the original trust-busters.This is ultimately an antitrust story. As we've discussed on the show with Tim Wu, Biden's chief antitrust enforcer, the concentration of corporate power is the great unfinished business of American democracy. Tecco makes the case that Big Med is where the trust busters should go next after Big Tech. UnitedHealth is now one of the largest employers of doctors in the country. So it wasn't exactly shocking when the UnitedHealth CEO was assassinated two years ago. The system isn't broken, Tecco suggests. It's working exactly as designed—just not for patients.Surgeon Robin Blackstone, MD, author of Doctor AI: Reimagining Health. Rebuilding Trust. Delivering Health 4.0, joins us in the second half of the show to offer a view from the front lines. After 30 years as a surgeon, Blackstone confirms everything Tecco diagnoses—and adds a chilling detail of her own: the system is priced entirely for fixing illness, not preventing it. Her prescription is a “triangle of trust” between patient, physician, and AI—with the patient finally owning their own data.Both agree on one thing: every dollar spent on public health saves $14.30 in medical and societal costs. We are all already paying for all the waste. We just need to fix Big Med. But who's going to do it? Tecco says that America is ready for another round of Obamacare politics. But I'm not so sure. Five Takeaways•       Healthcare Is a Tale of Two Civilizations: If you're wealthy, you go to UCSF and get the best care in the world. If you're not, you're one of the 100 million Americans without a regular primary care provider. Healthcare debt is the number one cause of bankruptcy. A person earning $30,000 in a rural county can expect to live a full decade less than someone earning $100,000 in an affluent suburb.•       The Real Winners Are Monopoly Medicine: Verticalized health plans now own the PBMs, the pharmacies, and increasingly the providers. The ACA's profit cap forced them to grow the pie instead of getting more efficient. United is now one of the largest employers of doctors in the country. Independent pharmacies are closing at the rate of one per day. Rite Aid is bankrupt—the only major chain not owned by a health plan.•       Every $1 in Public Health Saves $14.30: We're already paying for the crisis—in emergency room visits, lost productivity, and disability. We just need to move the safety net upstream. Public health is the only part of the system designed for prevention, yet its share of total health spending has dropped 25% in two decades. The economic case is overwhelming. The political will is not.•       AI Could Break the Information Asymmetry: Patients are already using ChatGPT to diagnose themselves—and sometimes it's saving their lives. One woman caught her own pneumonia because her doctor couldn't see her for a week. But some doctors want to keep the paternalism: one AI tool built on medical journals is restricted to clinicians only because making it available to patients would “piss off the doctors.”•       The System Is Priced for Rescue, Not Health: Everything is loaded to the moment your gallbladder goes bad or your heart gets a blockage. Prevention doesn't get paid for. Both guests agree: we need a massive re-pricing that rewards keeping people healthy, not just treating them when they're sick. That means paying doctors to prevent strokes, not just to fix them. About the GuestsHalle Tecco is the founder of the venture fund Rock Health and an investor in more than fifty digital health companies. She is an adjunct professor at Columbia Business School and a course director at Harvard Medical School. Her new book is Massively Better Healthcare: The Innovator's Guide to Tackling Healthcare's Biggest Challenges (Columbia University Press).Robin Blackstone, MD, is a physician, health systems architect, and founder of Blackstone Health. A surgeon by training with 30 years of clinical experience, she is the author of Doctor AI: Reimagining Health. Rebuilding Trust. Delivering Health 4.0.ReferencesPrevious Keen On episodes and authors mentioned:•       Robert Pearl on how AI will be monetized in the healthcare industry•       Tim Wu on the extractive economics of platform capitalism•       Zeke Emanuel on which country has the world's best healthcare•       Warren Buffett on healthcare costs as “a hungry tapeworm on the American economy”About Keen On AmericaNobody asks more awkward questions than the Anglo-American writer and filmmaker Andrew Keen. In Keen On America, Andrew brings his pointed Transatlantic wit to making sense of the United States—hosting daily interviews about the history and future of this now venerable Republic. With nearly 2,800 episodes since the show launched on TechCrunch in 2010, Keen On America is the most prolific intellectual interview show in the history of podcasting.WebsiteSubstackYouTubeApple Podcasts

Your hippocampus isn't a fixed shape, it's a garden. With the right sleep, movement, and purpose, it can actually grow larger and stronger at any age. In this episode, Sharlee Dixon sits down with Dr. Majid Fotuhi, a pioneering neurologist and neuroscientist with more than 35 years of experience in brain health, memory, neuroplasticity, and the prevention of Alzheimer's disease. Dr. Fotuhi earned his PhD in neuroscience from Johns Hopkins, completed his medical training at Harvard Medical School, and returned to Johns Hopkins for his neurology residency, where he now serves as an adjunct professor. Known for translating complex brain science into practical tools, his award-winning work has helped thousands improve memory, focus, and clarity. His expertise has been featured on CNN, NBC News, the Today Show, The New York Times, The Washington Post, and more. He is also the author of the new book “The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life.” In this conversation, Dr. Fotuhi shares the science behind his 12-week program and the everyday habits, movement, nutrition, mindset, stress control, purpose, and even embracing boredom, that help prevent cognitive decline and keep your mind sharp for life.   For more information about Dr. Majid Fotuhi, please visit: https://drfotuhi.com For more information about “The Invisible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life” by Dr. Majid Fotuhi, MD, PhD, please visit: https://drfotuhi.com/pre-order/ For more information about Dr. Fotuhi's online courses, please visit: https://drfotuhi.com/online-course-app/ For more information about The Invincible Brain App, please visit: https://invincible.drfotuhi.com Connect with Dr. Fotuhi on social media: Connect on YouTube: https://www.youtube.com/@DrFotuhi Connect on Instagram: https://www.instagram.com/dr_fotuhi/ Connect on TikTok: https://www.tiktok.com/@dr.fotuhi Connect on Facebook: https://www.facebook.com/drmajidfotuhi Connect on X: https://x.com/drfotuhi

In this episode, I sit down with the somatic psychotherapist, writer, and teacher Ailey Jolie to explore the evolving intersection of trauma, embodiment, and technology.Ailey shares her journey from eating disorder recovery to psychedelic-assisted research to writing, and her commitment to bringing body-based wisdom into mainstream psychology. She reflects on leaving modeling and medicine after listening to an unmistakable inner “no,” watching her mother make a life-defining decision guided by intuition, and how those early experiences shaped her trust in the body's voice.Ailey's credentials are impeccable. She holds a Master of Counseling Psychology, a Master of Arts in Depth Psychology with an Emphasis in Somatic Studies, and is a graduate of Harvard Medical School's Global Mental Health: Trauma Recovery Masters certificate program. She's a certified Focusing Oriented Therapist (FOT), Compassionate Inquiry Practitioner (CI), Certified Internal Family Systems Therapist (C-IFS), and Somatic Experiencing Practitioner (SEP). Furthermore, she has trained to deliver MDMA-assisted psychotherapy for PTSD (MAPS USA) and Ketamine-assisted psychotherapy in a research setting. She brings this wide range of experience to her Substack newsletter Words From This Body.In exploring AI as a kind of “spiritual technologist,” Ailey speaks candidly about her shifting relationship with screens, nervous system regulation, and the need to titrate between in-person depth and digital reach. Together, we discuss dorsal vagal “rest,” the somatic cost of not being believed, why trauma lives differently in female bodies, and the generational work of translating mind-body science — especially through a feminist lens — into something more accessible, embodied, and alive.LinksIn this Body, Ailey's podcast that explores the hidden impact of the unconscious In Body Method, Ailey's 14-week guided journey Words From This Body, Ailey's Substack newsletter

Show notes: (0:00) Intro (1:39) Why Alzheimer's is often overdiagnosed (3:25) The breakthrough discovery (8:39) 40-factor checklist (11:47) The impact of social engagement (15:52) The Five Pillars of Brain Health (18:53) What is brain training? (24:39) The best exercise for brain health (27:39) The "silent killer" of the brain (36:14) Mediterranean diet and brain inflammation (41:20) Reducing amyloid plaques (44:40) Most powerful brain foods (48:19) How to become a "Brain Super Ager." (51:44) Outro Who is Dr. Majid Fotuhi?   Dr. Majid Fotuhi is a neurologist, neuroscientist, and professor with over 35 years of experience specializing in brain health, memory, neuroplasticity, and Alzheimer's prevention. He earned his PhD in neuroscience from Johns Hopkins University, completed medical training at Harvard Medical School, and finished his neurology residency at Johns Hopkins, where he now serves as an adjunct professor.   His research has been widely published and cited internationally. Dr. Fotuhi developed a 12-week program that has helped thousands of patients with memory loss, brain fog, concussion, mild cognitive impairment, and early Alzheimer's disease. His work has been featured by major media outlets, including CNN, NBC News, Today, ABC News, The New York Times, The Washington Post, and The Times. Connect with Dr. Majid Website: https://drfotuhi.com/ LinkedIn: https://www.linkedin.com/company/neurogrow-brain-fitness-center/ IG: https://www.instagram.com/dr_fotuhi/ Pre-order the book: https://drfotuhi.com/pre-order/   Links and Resources: Peak Performance Life Peak Performance on Facebook Peak Performance on Instagram

We are in the information age and I don't believe there are any new topics and there is little, actual new information. But we can discover new insights and new angles and information that is more relevant for the current culture. And sometimes I just interest myself in an individual and their role within a topic and I want to hear their take on it. So with that said, in this episode I'm with Dr. Majid Fotuhi. Harper Collins, one of the world's big five publishers sent me a galley copy, which is a pre-copy before the book is actually published, of Majid's new book, “The Invincible Brain: The Clinically Proven Plan To Age-Proof Your Brain And Stay Sharp For Life.” I am very interested in brain health. I want to be cognitively sharp and able until my last breath. And I was interested in Majid's background. He  earned his PhD in Neuroscience from Johns Hopkins University and then his Medical Degree from Harvard Medical School, two institutions I greatly respect. Majid is currently an adjunct professor at the Mind/Brain Institute at Johns Hopkins University, while also teaching at George Washington University and Harvard Medical School. With 37 years of experience in teaching, clinical practice, and neuroscience research, Majid is a pioneer in enhancing brain vitality and cognitive performance and he developed a “Brain Fitness Program” that targets lifestyle optimization and cognitive stimulation to improve memory, focus, and overall brain health. The program has delivered measurable success for patients dealing with memory loss due to aging, concussions, and ADHD.  Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode Summary: In this enlightening conversation, Dr. Majid Fotuhi discusses the multifaceted nature of brain health, emphasizing the importance of understanding different types of intelligence, the power of practice and learning, and the interconnectedness of brain and body health. He addresses common misconceptions about memory and cognitive function, the impact of negative memories, and the role of genetics versus lifestyle in Alzheimer's disease. Dr. Fotuhi provides practical tips for enhancing brain function and encourages a holistic approach to maintaining cognitive health throughout life.Chapters00:00 Exploring Brain Intelligence03:02 The Power of Practice and Learning06:01 Understanding Memory and Cognitive Function08:39 The Interconnectedness of Brain and Body12:02 Overcoming Negative Memories and Trauma14:47 Alzheimer's Disease: Genetics vs. Lifestyle17:59 Holistic Approaches to Brain Health20:54 The Role of Stress and Emotional Well-being23:51 Practical Tips for Enhancing Brain Function26:55 Final Thoughts on Brain Health and LongevitySponsors: FATTY15 OFFER: Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/KIMBERLY and using code KIMBERLY at checkout.USE LINK: fatty15.com/KIMBERLY LMNTOFFER: Right now, for my listeners LMNT is offering a free sample pack with any LMNT drink mix purchase at DrinkLMNT.com/FEELGOOD. That's 8 single serving packets FREE with any LMNT any LMNT drink mix purchase. This deal is only available through my link so. Also try the new LMNT Sparkling — a bold, 16-ounce can of sparkling electrolyte water.USE LINK: DrinkLMNT.com/FEELGOOD Dr. Majid Fotuhi Resources: Book: The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life Website: neurogrow.com Social: YouTube @Dr. Majid Fotuhi Bio: Dr. Fotuhi earned his PhD in Neuroscience from Johns Hopkins University in 1992 and his Medical Degree from Harvard Medical School in 1997. Currently, he serves as an adjunct professor at the Mind/Brain Institute at Johns Hopkins University, while also teaching at George Washington University and Harvard Medical School.With 37 years of experience in teaching, clinical practice, and neuroscience research, Dr. Fotuhi has pioneered a multidisciplinary approach to enhancing brain vitality and cognitive performance at any age. His groundbreaking “Brain Fitness Program” combines a comprehensive baseline “Brain Portfolio” assessment with 12 bi-weekly brain training sessions. This program targets lifestyle optimization and cognitive stimulation to improve memory, focus, and overall brain health. Dr. Fotuhi's program has delivered measurable success for patients dealing with memory loss due to aging, concussions, and ADHD, as documented in several peer-reviewed journals. He is also the author of three books, including the highly acclaimed Boost Your Brain: The New Art and Science Behind Enhanced Brain Performance. Recognized as one of the leading experts in memory and successful aging, Dr. Fotuhi has delivered lectures at academic institutions and major organizations in over 20 countries – including a TEDx presentation in the Philippines. Passionate about sharing the latest discoveries in the field of brain rehabilitation and neuroplasticity, he has been featured in interviews with more than 50 prominent media outlets in the United States and around the globe.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Everyone is at risk of breast cancer. Some are more at risk than others due to hereditary factors – such as a family history of cancers – and lifestyle choices that affect our overall health. Knowing your risk of breast cancer can help you decide what steps to take to lower your risk. Joining me today is Dr. Jennifer Ligibel, a Susan G. Komen Scholar and Komen grantee, Professor of Medicine at Harvard Medical School, Senior Physician at the Dana-Farber Cancer Institute and an expert on the impact of lifestyle factors, cancer risk and outcomes. Through more than a dozen lifestyle intervention trials, Dr. Ligibel has evaluated the impact of exercise, weight loss, fitness, body composition and quality of life in cancer patients and survivors.

This time on Code WACK!  Millions of Americans have health insurance, but still can't afford to use it. So what happens when high deductibles and corporate profit pressures shape the care patients receive? To break it down, we spoke with Dr. Adam Gaffney - a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's also a former president of Physicians for a National Health Program, and his work focuses on health care financing and national reform. This is the second episode in a two-part series. Check out the Transcript and Show Notes for more!  Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.   

This time on Code WACK! Millions of Americans have health insurance, but still can't afford to use it. So what happens when high deductibles and corporate profit pressures shape the care patients receive? To break it down, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's also a former president of Physicians for a National Health Program, and his work focuses on health care financing and national reform. This is the second episode in a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

What is the real killer when it comes to heart disease? Can the right cardiac testing truly mean the difference between life and death? In today's episode, we are joined by Dr. John Osborne, a Harvard-trained, triple board-certified cardiologist and Co-Founder of ClearCardio, to break it all down… Dr. Osborne earned his B.S. with honors from Penn State University, his M.D. magna cum laude from Jefferson Medical College, and a Ph.D. in cardiovascular physiology from Thomas Jefferson University. His postdoctoral training at Harvard Medical School and Brigham and Women's Hospital helped shape his expertise in non-invasive cardiology. Board-certified across multiple disciplines, his work focuses on preventive cardiology, metabolic syndrome, and cardiovascular genetics. Recognized as the American Heart Association's Cardiac Care Provider of the Year and named a Top Doctor multiple times, Dr. Osborne has authored original research papers, book chapters, and delivered hundreds of international presentations. Through ClearCardio, he is advancing proactive cardiac care by integrating AI-powered imaging to detect plaque earlier, quantify risk more precisely, and empower patients before symptoms appear. In this episode, we dive into: What actually causes heart attacks and sudden cardiac death. The role of soft plaque vs calcified plaque in coronary artery disease. Why many heart attacks happen after a "normal" stress test. The limits of stents and why they do not necessarily extend longevity. To learn more about Dr. Osborne and his work with ClearCardio, connect with him on LinkedIn!

There is a palpable mix of excitement and anxiety about the latest impending wave of Artificial Intelligence. AI tools are being developed that will fundamentally impact our jobs, our relationships, our access to knowledge and creativity, our children's lives, and our planet. But for an industry like healthcare — where fax machines and pagers are common, where people struggle to find affordable care or adequate resources, and nurses are leaving the profession due to administrative burdens and moral distress — can AI be an answer?  In this two-part feature of our AI in Play series, where we explore AI's role in transforming healthcare, host Oriana Beaudet, Vice President of Innovation at the American Nurses Association, Credentialing Center, and Foundation, talks with a nurse and a clinician helping to shape the future of AI in healthcare for one of the largest technology companies in the world.   Episode 130 features nurse Mary Varghese-Presti, Corporate VP and COO of Microsoft Health and Life Sciences, whose team built Dragon Copilot, the first commercially available ambient AI solution purpose-built for nursing workflows. We learn how Microsoft co-designed this tool directly with staff nurses, nurse managers, and nurse executives across more than 10 health systems,  and why that collaboration is essential. We'll learn about Microsoft's vision for a three-stage AI future, from co-pilots to agents to a true hybrid workforce, and what it would mean for nurses to have the ability to delegate tasks the way physicians have long been able to do. Finally, we hear the deeply personal story behind Mary's mission,  from growing up in an immigrant household surrounded by nurse "aunties," to advocating for a voiceless patient at 4 am as a young nurse at Johns Hopkins, to now leading the technology that she believes will restore humanity and dignity to the very profession that shaped her.  Episode 131 features Dominic King, former surgeon and VP of Health at Microsoft AI, where his team builds and scales consumer health tools that see more than 50 million health-related sessions a day. In this conversation, we learn about Microsoft's partnership with Harvard Medical School and how it's working to ensure that the billions of health questions people ask AI every day are met with credible, clinically sound information. We also hear how he thinks about patient safety and trust in AI, and we'll get his candid take on what AI cannot replace, why clinicians must be central to scaling these tools beyond the pilot stage, and how he believes technology is the single biggest lever for making health systems sustainable in the face of growing global demand.      For more information on the podcast bundles, visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.    Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com.       

There is a palpable mix of excitement and anxiety about the latest impending wave of Artificial Intelligence. AI tools are being developed that will fundamentally impact our jobs, our relationships, our access to knowledge and creativity, our children's lives, and our planet. But for an industry like healthcare — where fax machines and pagers are common, where people struggle to find affordable care or adequate resources, and nurses are leaving the profession due to administrative burdens and moral distress — can AI be an answer?  In this two-part feature of our AI in Play series, where we explore AI's role in transforming healthcare, host Oriana Beaudet, Vice President of Innovation at the American Nurses Association, Credentialing Center, and Foundation, talks with a nurse and a clinician helping to shape the future of AI in healthcare for one of the largest technology companies in the world.   Episode 130 features nurse Mary Varghese-Presti, Corporate VP and COO of Microsoft Health and Life Sciences, whose team built Dragon Copilot, the first commercially available ambient AI solution purpose-built for nursing workflows. We learn how Microsoft co-designed this tool directly with staff nurses, nurse managers, and nurse executives across more than 10 health systems,  and why that collaboration is essential. We'll learn about Microsoft's vision for a three-stage AI future, from co-pilots to agents to a true hybrid workforce, and what it would mean for nurses to have the ability to delegate tasks the way physicians have long been able to do. Finally, we hear the deeply personal story behind Mary's mission,  from growing up in an immigrant household surrounded by nurse "aunties," to advocating for a voiceless patient at 4 am as a young nurse at Johns Hopkins, to now leading the technology that she believes will restore humanity and dignity to the very profession that shaped her.  Episode 131 features Dominic King, former surgeon and VP of Health at Microsoft AI, where his team builds and scales consumer health tools that see more than 50 million health-related sessions a day. In this conversation, we learn about Microsoft's partnership with Harvard Medical School and how it's working to ensure that the billions of health questions people ask AI every day are met with credible, clinically sound information. We also hear how he thinks about patient safety and trust in AI, and we'll get his candid take on what AI cannot replace, why clinicians must be central to scaling these tools beyond the pilot stage, and how he believes technology is the single biggest lever for making health systems sustainable in the face of growing global demand.    For more information on the podcast bundles, visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.    Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com. 

On this episode of the AMSSM Sports Medcast (X: @TheAMSSM), host Dr. Jeremy Schroeder, DO (X: @thejschro), is joined by Dr. Adam Tenforde, MD, to provide a preview of the Extracorporeal Shockwave Therapy (ESWT) Pre-Conference that will take place during the 2026 AMSSM Annual Meeting. Dr. Tenforde is a sports medicine physician and an assistant professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He is also the Director of Running Medicine at Spaulding National Running Center and the Co-Director of Harvard Sports Medicine. As a former elite distance runner, he has a great interest in running medicine, bone health, prevention, and management of overuse injuries. In-person and virtual attendance options are still available for the conference. Register to attend the 2026 AMSSM Annual Meeting at annualmeeting.amssm.org.

In today's episode, we sat down with Sarah Sammons, MD. Dr Sammons is associate director of the Metastatic Breast Cancer Program and a senior physician at Dana-Farber Cancer Institute, as well as an assistant professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In our exclusive interview, Dr Sammons discussed the rationale for and findings from a phase 2 study (NCT06449222) evaluating the PD-L1– and VEGF-A–directed bispecific antibody pumitamig (BNT327/BMS986545) in patients with locally advanced or metastatic triple-negative breast cancer (TNBC), as well as what these data may mean for the TNBC treatment paradigm.

These days people are using AI chatbots for everything. These chatbots have a wealth of information at their metaphorical fingertips. But the accuracy of the information that they offer us is, well, questionable. But it makes sense why some people turn to AI for medical advice. They’re usually free, which gives them an upper hand when healthcare in the United States is so expensive. They’re also easy to access, so people can get their questions answered immediately, instead of waiting for an opening at their doctor’s office. And they’re trained to be empathic, which is especially appealing to patients who don’t feel valued in medical settings. In this "Ask a Doctor" segment, we explore the world of health advice and chatbots with two medical professionals. Guests: Angad Singh is a family medicine physician. He's also an Associate Chief Clinical Information Officer and Clinical Associate Professor at UW Medicine. Danielle Bitterman is an assistant Professor at Harvard Medical School and Clinical Lead for Data Science and AI at Mass General Brigham. Related links: A.I. Chatbots Are Changing How Patients Get Medical Advice - The New York Times How to Use ChatGPT for Health Advice | Right as Rain Health Advice From A.I. Chatbots Is Frequently Wrong, Study Shows - The New York Times Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Last time we talked about kidney xenotransplantation, we were joined by Towana Loony and Tim Andrews, who shared their personal experiences with receiving a xenotransplant. Today, two doctors who helped propel xenotransplantation forward, Dr. Vineeta Kumar and Dr. Leonardo Riella, are here to explain the science and what comes next. This episode is supported by eGenesis and United Therapeutics In this episode we heard from:  Vineeta Kumar is the lead nephrologist for UAB's Living Kidney Donor and Incompatible Kidney Transplant programs. She is an expert in kidney transplantation, living kidney donation, incompatible kidney transplant, kidney paired donation and cardiovascular outcomes after kidney transplantation. Kumar also engages in research in the prevention, treatment and prognosis of antibody mediated rejection. She has been named a "Top Doctor" by U.S. News & World Report each year since 2012. She has been lead facilitator of the UAB Schwartz Rounds since 2009, a program that brings together nurses, physicians, social workers, and other providers to discuss delivery of compassionate care. She was awarded the Brewer-Heslin Endowed Award for Professionalism in Medicine for the highly skilled and compassionate medical care she provides to her patients. Kumar was recently named "Best Educator" by the 2018, 2019 and 2020 UAB Medical School classes. She has previously served on the Education Committee for the American Society of Transplantation. Leonardo V. Riella, M.D., Ph.D. is the Harold and Ellen Danser Endowed Chair in Transplant Surgery at Harvard Medical School and the Medical Director of Kidney Transplantation at Massachusetts General Hospital. His research focuses on mechanisms of immune regulation and the development of novel therapies to promote transplant tolerance. In addressing kidney disease recurrence post-transplantation, he founded and leads the TANGO Consortium, the largest global effort dedicated to studying glomerular disease recurrence. In March 2024, Dr. Riella led the world's first successful kidney xenotransplant from a gene-edited pig into a living human. He now leads the first FDA-approved pilot study in kidney xenotransplantation and is conducting high-dimensional immune profiling studies to characterize the human xeno-immune response and guide immunosuppressive strategies. Find out more about Dr. Riella's research here.     Additional Resources Xenotransplantation Information   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Bruce Chabner is a professor of medicine at Harvard Medical School and clinical director emeritus of the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.D. Goldman and B.A. Chabner. Cerebral Folate Deficiency, Autism, and the Role of Leucovorin. N Engl J Med 2026;394:833-835.

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis sat down with guest Susana M. Campos, MD, MPH. Dr Campos is the clinical director and director of Educational Initiatives for the of the Division of Gynecologic Oncology at Dana-Farber Cancer Institute, and an institute physician and assistant professor of medicine at Harvard Medical School in Boston, Massachusetts. Drs Matulonis and Campos discussed the evolving landscape of newly diagnosed cervical cancer, from epidemiologic trends to emerging therapeutic strategies.According to 2026 estimates from the American Cancer Society, approximately 13,400 new cases of invasive cervical cancer will be diagnosed in the United States, with roughly 4200 deaths. Although incidence has declined over time due to human papillomavirus (HPV) vaccination and screening efforts, rates have plateaued, and the disease burden remains substantial, particularly among women aged 35 to 64 years. Dr Campos noted that approximately half of cases occur in women younger than 50 years of age, and about 20% are diagnosed in women older than 65 years of age.Dr Campos reviewed common presenting symptoms, including abnormal vaginal bleeding, intermenstrual or postmenopausal bleeding, abnormal discharge, pelvic pain, and, in advanced cases, urinary symptoms or leg swelling. She explained that diagnosis begins with pelvic examination and cervical cytology or HPV testing, followed by colposcopy and biopsy when indicated. Although cervical cancer remains one of the few malignancies that is clinically staged, imaging modalities, such as MRI, CT, and PET scans, are critical to accurately defining disease extent, they underscored. Moreover, the discussion highlighted transformative advances in locally advanced disease. The phase 3 KEYNOTE-A18 trial (NCT04221945) demonstrated improved progression-free and overall survival with the addition of pembrolizumab (Keytruda) to standard chemoradiation, establishing a new standard for high-risk patients, Campos stated. Similarly, the phase 3 INTERLACE trial (NCT01566240) showed that short-course induction chemotherapy with carboplatin and paclitaxel before chemoradiation improved long-term outcomes. Campos forecasted that ongoing studies, including the phase 3 NRG-GY037 trial (NCT07061977), may integrate these approaches and further refine optimal treatment sequencing.Lastly, Drs Matulonis and Campos highlighted the expanding therapeutic arsenal in the recurrent and metastatic setting. Campos noted how antibody-drug conjugates, such as tisotumab vedotin-tftv (Tivdak) and fam-trastuzumab deruxtecan-nxki (Enhertu), have demonstrated meaningful activity, particularly in biomarker-selected populations. Campos added that investigational strategies targeting TROP2, such as sacituzumab govitecan-hziy (Trodelvy), represent additional promising avenues.Despite these advances, both experts emphasized that prevention remains paramount. Widespread uptake of HPV vaccination, including the 9-valent vaccine, as well as adherence to routine cervical screening, are essential to reducing the long-term burden of this largely preventable disease.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Jodi Gilman, Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Jodi Gilman, Associate Professor of Psychology in the Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. In the February 2026 podcast Jodi Gilman talks about their secondary analysis of a randomised clinical trial looking at cannabis use and nicotine vaping cessation outcomes among adolescents and young adults. Participants were 16 to 25 and reported vaping nicotine regularly and did not smoke tobacco. The full study assessed the efficacy of varenicline for nicotine vaping cessation. For more detail on the parent trial listen to the interview with Eden Evins in the April 2025 podcast. Jodi Gilman discusses the finding that, among adolescents and young adults attempting to reduce or stop nicotine vaping, baseline cannabis use was not associated with nicotine vaping abstinence. Varenicline was helpful for nicotine vaping cessation regardless of cannabis use. This finding indicates that co-use of cannabis may not be a barrier to successful nicotine vaping cessation treatment. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Reference for the paper by Gilman discussed in this podcast, January 2026 search: 10.1001/jamanetworkopen.2025.47799. Parent study by Evins: 10.1001/jama.2025.3810. Our searches for the EC for smoking cessation review carried out on 1st February 2026 found: 4 linked reports (10.1016/j.cct.2026.108215; 1; 0.1111/add.70294; 10.1007/s11606-024-08797-5; 10.1016/j.lana.2025.101351) Our search for our interventions for quitting vaping review carried out on 1st February 2026 found: 1 new study (10.1111/jrh.70109) and 2 linked reports (10.1002/adaw.34496; 10.1007/s11606-024-08797-5). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full This podcast is supported by Cancer Research UK.

Dr. Ross Greene's work has profoundly shaped how so many of us think about kids' behavior and what they actually need from the adults in their lives, so I'm thrilled to welcome him back to the show to talk about his brand new book, The Kids Who Aren't Okay: The Urgent Case for Reimagining Support, Belonging, and Hope in Schools. Together, we explore the urgent need to reimagine how we support children in schools, especially as mental health concerns continue to rise. We dig into the importance of recognizing developmental variability, why meeting kids where they are is non-negotiable, and how current behavior-focused systems miss the real problems underneath. Ross also highlights the role parents and caregivers can play in advocating for meaningful change. About Dr. Ross Greene  Ross W. Greene, Ph.D., is a clinical psychologist and the originator of the innovative, evidence-based approach called Collaborative & Proactive Solutions (CPS), as described in his influential books The Explosive Child, Lost at School, Lost & Found, and Raising Human Beings. He also developed and executive produced the award-winning documentary film The Kids We Lose, released in 2018. Dr. Greene was on the faculty at Harvard Medical School for over 20 years, and is now founding director of the non-profit Lives in the Balance. He is also currently adjunct Professor in the Department of Psychology at Virginia Tech and adjunct Professor in the Faculty of Science at the University of Technology in Sydney, Australia. Dr. Greene has worked with several thousand kids with concerning behaviors and their caregivers, and he and his colleagues have overseen implementation and evaluation of the CPS model in countless schools, inpatient psychiatric units, and residential and juvenile detention facilities, with dramatic effect: significant reductions in recidivism, discipline referrals, detentions, suspensions, and use of restraint and seclusion. Dr.Greene lectures throughout the world and lives in Freeport, Maine. Things you'll learn from this episode  How kids today are facing unprecedented challenges that require new ways of thinking and responding Why developmental variability matters and why every child needs support tailored to their unique profile How schools can create more supportive ecosystems by using proactive rather than reactive approaches Why behavior is often a late signal of unmet expectations, not the problem itself How managing expectations and understanding root causes can reduce concerning behaviors Why parents' advocacy and the Collaborative & Proactive Solutions model can transform how children are supported in education Resources mentioned The Kids Who Aren't Okay: The Urgent Case for Reimagining Support, Belonging, and Hope in Schools by Dr. Ross Greene Never Too Early: CPS with Young Kids (documentary) The Explosive Child: A New Approach for Understanding and Parenting Easily Frustrated, Chronically Inflexible Children by Dr. Ross Greene Lives in the Balance (Dr. Greene's website) The B Team (Facebook group) Lost at School: Why Our Kids With Behavioral Challenges are Falling Through the Cracks and How We Can Help Them by Dr. Ross Greene Raising Human Beings: Creating a Collaborative Partnership with Your Child by Dr. Ross Greene Lost and Found: Helping Behaviorally Challenge Students (and While You're At It, All the Others by Dr. Ross Greene The Kids We Lose (documentary) How to Parent Angry and Explosive Children, with Dr. Ross Greene (Tilt Parenting podcast) Ken Wilbur Learn more about your ad choices. Visit podcastchoices.com/adchoices

Conversations about brain health have been dominated by a competing mix of fatalism and over-promising, with aging framed as inevitable decline and "brain optimisation" sold through weak evidence. So how should we think about cognition across the lifespan? In this episode, we explore the idea that neuroplasticity does not disappear in adulthood, but instead continues to respond, for better or worse, to repeated behaviours and exposures. Much of what is labelled age-related cognitive decline may in fact reflect an accumulation of modifiable risk factors. We also dig into how to critically evaluate brain-health claims and how lifestyle pillars such as exercise, sleep, diet, stress reduction and cognitive training fit into a coherent framework. The discussion extends to emerging multimodal intervention programs, their promising signals and their clear limitations, and to a broader, multifactorial view of Alzheimer's disease that moves beyond a narrow amyloid-centric model. Finally, we examine the role of genetics, including ApoE4, and why genetic risk does not equate to biological destiny, even later in life. Dr. Majid Fotuhi is a neurologist and an adjunct professor at the Johns Hopkins Mind/Brain Institute. He earned his medical degree from Harvard Medical School and completed a Ph.D. in neuroscience at Johns Hopkins University. That was followed by internship and neurology residency at Johns Hopkins Hospital. Timestamps [03:41] Understanding neuroplasticity [05:22] Risk factors for cognitive decline [07:07] Evidence-based interventions for brain health [09:37] The five pillars of brain health [10:42] Dr. Fotuhi's multimodal program [19:09] Measuring cognitive function [24:43] The role of amyloid and tau in Alzheimer's [27:53] Genetics and lifestyle in brain health [30:03] Debunking myths and overhyped claims [36:08] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Fotuhi's book: The Invincible Brain

Bone loss doesn't start when fractures happen — it begins years earlier. In this episode, we explore how bone aging accelerates during menopause and the emerging role of the gut microbiome as a driver of skeletal decline. Dr. Kara Fitzgerald speaks with research scientists from Sōlaria biō, the company behind Bōndia, about their work studying plant-derived microbes, microbial synergies, and the connections between gut health, inflammation, and bone loss in peri- and postmenopausal women. We also review findings from a randomized, placebo-controlled clinical trial examining a microbiome-based intervention for bone health — and discuss why bone loss may need to be addressed earlier, systemically, and beyond hormones alone. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Alicia Ballok, Ph.D. is Director of Discovery at Sōlaria biō, leading research on plant-derived synbiotics for inflammatory and immune-mediated diseases. Trained in Microbiology and Immunology at Dartmouth, with postdoctoral work at Harvard Medical School and Massachusetts General Hospital, her work focuses on translating host–microbe science into therapeutic innovation. Mark Charbonneau, Ph.D. is Vice President of R&D at Sōlaria biō. He earned his Ph.D. in Computational and Systems Biology at Washington University in St. Louis, studying infant microbiome development and undernutrition. His work spans microbiome research, bioinformatics, and live biotherapeutic innovation. THANKS TO OUR SPONSOR Sōlaria biō: http://bit.ly/SolariaBio EXCLUSIVE OFFER FOR NEW FRONTIERS LISTENERS Looking for a clinically proven way to target bone loss? Bōndia by Sōlaria biō is a groundbreaking blend of plant-derived prebiotics and probiotics shown in a clinical trial to improve bone density outcomes by 85%. Try it for yourself at Sōlaria biō and use code Kara20 for 20% off your order. CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney - a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more!  Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.   

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

From Music to Medicine: Rethinking Clinical Trials, AI, and Real-World Evidence On this episode Gil and Gregg welcome Amir Lahav, MD, ScD, founder and CEO of SkyMedAI and curator of the Digital Health AI Innovation Summit in Boston. Dr. Lahav traces his unlikely path from working musician to Harvard Medical School faculty, Pfizer rare-disease innovator, and now advisor to digital health and life sciences companies. The conversation explores how music-driven neurorehabilitation helped stroke survivors regain motor function, why traditional snapshot-based clinical trials are “embarrassingly wrong” for real-world patients, and how AI and wearables can turn continuous data into earlier detection and more humane care. Lahav also warns about overconfident, under-validated AI and argues that the most successful health companies by 2030 will be those that know when not to use AI. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, we explore the treatment algorithm for adult ADHD with Dr. Oscar Bukstein from Harvard Medical School. Should you start with stimulants or non-stimulants when substance use disorder complicates the picture? Discover how comorbidities like depression and anxiety reshape your medication selection strategy for optimal patient outcomes. Faculty: Oscar G. Bukstein, M.D., M.P.H Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Mastering Adult ADHD: A Comprehensive Clinical Guide Treatment Algorithm for Adult ADHD

In this episode of Do Good to Lead Well, I welcome Dr. Jacqueline Sperling, a clinical psychologist, assistant professor in psychology at Harvard Medical School, and the co-founder and co-program director of the McLean Anxiety Mastery Program at McLean Hospital to discuss her latest book, “Find Your Fierce: How to Put Social Anxiety in Its Place.”Motivated by long waitlists at treatment centers and the slow path many face toward accessing help for social anxiety, Jacqueline Sperling shares her mission: to offer practical, evidence-based tools that anyone can use, regardless of clinical diagnosis or age. She grounds her message in empowerment, emphasizing that anxiety is a universal emotion—sometimes adaptive, sometimes disruptive—but always manageable with the right approach.Major themes include: • Understanding Anxiety: Dr. Sperling defines anxiety as a forward-looking form of fear and reframes it as a resource that can help us prepare for life's challenges, provided we don't let it dominate our decision-making. • The Thoughts-Feelings-Behaviors Model: Our discussion breaks down how our internal dialogue, emotions, and actions interconnect. Techniques like “stop, drop, and roll” and identification of unhelpful thought categories (catastrophizing, shoulds, overgeneralizing) are brought to life through questions from the live audience. • Leadership and Team Dynamics: We explore how leaders can compassionately address anxiety in their teams, foster psychological safety, and model healthy boundaries, which are especially during disruptive times and organizational uncertainty.Check out this episode for an honest, caring invitation for how we can create lasting mental health hygiene: a daily, mindful practice to care for ourselves, as we pursue meaningful work and lead with compassion.What You'll Learn- How to flip the script when you always expect the worst.- How leaders can compassionately support team members stuck in negative thought cycles.- Strategies for dealing with imposter syndrome and perfectionism.- Practical tips for receiving feedback without defensiveness.- Ways to maintain resilience in uncertain, disruptive times.- The power of mental health hygiene.Podcast Timestamps02:15 Dr. Jacqueline Sperling's background04:07 Origin story of "Find Your Fierce" book05:48 Understanding anxiety vs. fear07:49 The three-component model (thoughts, feelings, behaviors)10:04 Stop, drop, and roll technique14:23 Managing catastrophizing in team members18:54 Addressing imposter syndrome23:01 Overcoming fear of speaking up in meetings28:08 Values-based anxiety management31:53 The "shoulds" and "musts" trap33:51 Receiving feedback effectively38:03 Managing team anxiety during disruption40:06 Addressing perfectionism44:40 Delegation and leadership anxiety48:33 Overgeneralizing dangers52:07 Mental health hygiene practicesKEYWORDSPositive Leadership, Managing Anxiety, Social Anxiety, Thought-Feeling-Behavior Model, Catastrophizing, Mindfulness, Imposter Syndrome, Perfectionism, Exposure Therapy, Behavioral Experiments, Self-insight, Mental Health Hygiene, Resilience, Stress Management, Reframing, Team Dynamics, Sleep Hygiene, Self-care, CEO Success

Dr. Halley Alexander and Dr. Alissa M. D'Gama discuss genetic testing for infantile epilepsies.  Show citation:  Nguyen JNH, Lachgar-Ruiz M, Higginbotham EJ, et al. Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy. Neurology. 2026;106(6):e214645. doi:10.1212/WNL.0000000000214645  Show transcript:  Dr. Halley Alexander:  Hi, this is Halley Alexander with today's Neurology Minute, and I'm here with Dr. Alissa D'Gama from Boston Children's Hospital and Harvard Medical School, and we just finished recording a full-length podcast about some exciting new work in genetic testing for infantile onset epilepsies. Alissa, can you tell us what you found briefly and why it's important for neurology care? Dr. Alissa D'Gama:  Infantile epilepsies are relatively common, and they're associated with substantial burden of disease, and we know that identifying underlying genetic causes can impact clinical care. It's important for emerging precision therapies. But even after genome sequencing, which is the most comprehensive clinical genetic testing currently available, most infants remain genetically unsolved. And so what we did was take that genome sequencing data and reanalyze it for a cohort of infants who had unexplained non-acquired epilepsy and non-diagnostic genome sequencing, and in about 5% of cases, our reanalysis was able to identify a genetic diagnosis, and all of these diagnoses had impact on clinical care for their infants and their families. In some cases, we could incorporate new information, either new clinical information about the patient or new scientific methods or information about disease associations, and in other cases, we were able to incorporate new analysis methods to identify variants. And so our findings suggest that implementing reanalysis for infants or any individual with epilepsy within a year or two of non-diagnostic testing may be useful. Dr. Halley Alexander:  Thank you so much, and you can find a lot more details by listening to the full-length podcast, which is available now on the Neurology podcast, and you can find the full article in the March 10th issue of Neurology or online at neurology.org. As always, thanks for tuning in for today's Neurology Minute. 

In this episode, host Sandy Vance chats with Dr. Sean Kelly, the Chief Medical Officer and the SVP of Customer Healthcare Strategy at Imprivata. Together, they unpack how healthcare organizations can strengthen cybersecurity without slowing clinicians down—exploring everything from mobile device security and passwordless authentication to adaptive authentication, risky user behaviors, and the very real implications for patient safety, workflow efficiency, and ROI for healthcare leaders.In this episode, they talk about:How cybersecurity can be improvedThe impact that Imprivata has on clinicians Why multi-factor authentication systems aren't more prevalent in the healthcare industryThe risky behaviors that open up organizations to security risksThe different things that Imprivata offers organizationsThe risks of patient harm in cybersecurity and privacyAdvice for CIOs or CFOs: workflow implications, security compliance, security and efficiency ROI, and financial valueAdaptive authentication at ImprivataA Little About Sean:Dr. Sean Kelly brings a uniquely well-rounded perspective to healthcare, shaped by a career that spans emergency medicine, healthcare leadership, technology, teaching, and entrepreneurship. An emergency physician at Beth Israel Lahey Health in Boston and an Assistant Clinical Professor of Emergency Medicine at Harvard Medical School, he is also the Chief Medical Officer and SVP of Customer Healthcare Strategy at Imprivata, where he helps guide product vision, go-to-market strategy, and customer experience after more than a decade with the company from startup through IPO and private equity ownership. He has led high-performing teams in both clinical and executive settings, contributed to care delivery improvements impacting millions of patients, published widely in emergency medicine and medical education, and earned multiple teaching awards. His background includes training at Harvard College, UMass Medical School, and Vanderbilt University, co-founding a concierge medical practice on Martha's Vineyard, international teaching and humanitarian work, and service in roles ranging from hospital administration to disaster relief—all grounded in a deep commitment to learning, mentorship, and collaboration.

In this episode of Revolutionary Women, I speak with Kyla Reynolds P'an, Head of Development for Pangea Trust, a UK–Portugal charity building Europe's first large-scale elephant sanctuary in Portugal's Alentejo region. Pangea Trust is creating a sanctuary for elephants currently living in captivity across Europe, offering a lifelong home designed for recovery, space, and social connection. We discuss what it takes to build an elephant sanctuary from the ground up, from fundraising and public awareness to infrastructure, international logistics, and preparing for the arrival of Kariba, the sanctuary's first elephant, expected in 2026. Beyond wildlife conservation, this conversation explores career evolution, living between cultures, and how seasons of work, including raising a family, shape the paths we take later. Kyla shares what it looks like to step into a new chapter with clarity and purpose. If you're interested in elephant conservation, nonprofit leadership, philanthropy in Europe, or stories of women creating change in their communities, this episode offers both depth and perspective. Kyla Reynolds P'an is Head of Development for Pangea Trust, a UK/Portugal based charity building Europe's largest and most comprehensive elephant sanctuary in the Alentejo region of Portugal. The sanctuary will serve as a compassionate solution for Europe's zoos and circuses seeking a life-long home for their elephants. Kyla holds a Master's in Journalism and is the mom of two teenagers. She has more than 20 years of front-line development experience under her belt, including the Smithsonian Institution, Boston University, Harvard Medical School and Mass Audubon. To Learn More about Kyla Reynolds P'an: LinkedIn: https://www.linkedin.com/in/kyla-p-an-59b1131/ To learn more about Pangea Trust: Home - Pangea Trust (2) Pangea Trust: Posts | LinkedIn (20+) Facebook (7) Instagram . . . . . Time to Shine by tubebackr & Popsicles https://soundcloud.com/tubebackr https://soundcloud.com/popsiclesmusic Creative Commons — Attribution-NoDerivs 3.0 Unported — CC BY-ND 3.0 Free Download / Stream: https://www.audiolibrary.com.co/tubebackr-and-popsicles/time-to-shine Music promoted by Audio Library https://youtu.be/Cvbjhx6X4ZY

I want to start off by asking a question I continually interest myself with. Do we really want to be happy? If I survey the culture, it looks like we very much want happy moments. The little jolts of dopamine from entertainment, food, drugs and such. But do we really want deep and abiding happiness in our souls? Because if we do, then our primary interest would be in relationships. But not just any relationships. I'm revisiting a conversation I had with Robert Waldinger. Robert is a professor of psychiatry at Harvard Medical School and director of the Harvard Study of Adult Development at Massachusetts General Hospital which has been going on for 87 years. His devotion is on what most equates to human happiness, and the answer is, relationships. But let me point out that Robert himself is a Zen master and teaches meditation around the world. Which is a focus on what I feel is our first and most important relationship. The relationship with ourselves. I have continued to grow in appreciation, not just for the message, but for Robert himself. If you have my book, What Drives You, you'll see his endorsement. Roberts book, which is how I came to know of him, is, The Good Life: Lessons From the World's Longest Scientific Study on Happiness. And you type in, “Robert Waldinger TED” you will find his TED talk, titled, What Makes A Good Life, that between postings on both YouTube and TED has over 80 million views. Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare.  Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health.  He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School.  He was also Professor of Law and Public Health at the Harvard Chan School of Public Health.  Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles. 

Read "ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature" – co-authored by Dr. Anthony L. Komaroff & W. Ian Lipkin. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1187163/full    Fatigue is the body's hard-wired response to a viral infection. In today's episode, Haylie Pomroy shares insights with Dr. Anthony L. Komaroff to examine the history of ME/CFS research, the causes and triggers of ME/CFS and other post-infectious chronic illnesses, and the abnormalities observed in the brain and autonomic nervous system among patients with ME/CFS and long COVID. Dr. Komaroff also addresses how patients have often been dismissed within the healthcare system, explains the physical and psychological processes involved in these conditions, and discusses how he and other clinicians are now moving to the forefront of diagnosis and treatment.   Register for the Integrative Medicine Luncheon featuring Dr. Payam Hakimi on  February 14, 2026. https://nova.zoom.us/meeting/register/RQnykYIKRZO-yVykmDp-YQ#/registration   Dr. Anthony L. Komaroff is a distinguished Professor of Medicine at Harvard Medical School and a Senior Physician at Brigham and Women's Hospital. He has held significant leadership roles, including Director of the Division of General Medicine and Primary Care at Brigham and Women's Hospital. Dr. Komaroff is known for his research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and human herpesvirus infections. He has published over 270 research articles and book chapters and served on numerous advisory committees for major health organizations.   LinkedIn: https://www.linkedin.com/in/anthony-l-komaroff-64133346/  Facebook: https://web.facebook.com/anthonyl.komaroff    Solve ME: https://solvecfs.org  Open Medicine Foundation: https://www.omf.ngo  National Institutes of Health (NIH): https://www.nih.gov/mecfs/about-mecfs  Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/me-cfs/about/index.html   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others. You can also watch the show on our YouTube.https://www.youtube.com/@NSU_INIM   Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d    This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here.   Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM

“My times were dropping and it was so exciting. Every week, they were dropping, dropping, dropping. It was pretty early in the season, too. At that point, I hadn't even made NCAAs. At the time when I ran 2:00, I had the number one time in the country. There was a lot that happened super fast… I think that was my favorite race of my life. I never even thought in my mind that I could run 2:00 even earlier on in the season. It broadened the horizons of what I think I'm capable of in the future and to never limit myself.”My guest for today's episode is Victoria Bossong. This week on the podcast, CITIUS MAG is bringing you interviews with some of Team New Balance's latest signees as we celebrate five years of partnering with them on all things from the high school to the professional front. Yesterday, we brought you an interview with Roisin Willis and now we've got another strong rising 800m runner.Victoria was a star high school sprinter in Maine who almost on a whim tried the 800m late into her prep career and found success. Fast forward a few years and she's fully committed to the event. In 2025 while at Harvard, she was the NCAA Indoor Championships runner-up and ran an outdoor personal best of 1:59.48. She just opened up her indoor season as a pro with an indoor 1000m PB of 2:36. Off the track, she's just as impressive. She has her degree in neuroscience and has worked in a Harvard Medical School lab. In our chat, she discusses how she managed to balance all of that as a student-athlete, how she comes at the 800m from more of a sprinter background, and her goals for her first professional season.____________Host: Chris Chavez | ⁠⁠@chris_j_chavez on Instagram⁠Guest: Victoria Bossong | @victoriabossong on InstagramProduced by: Jasmine Fehr | ⁠⁠⁠@jasminefehr on Instagram⁠⁠⁠____________SUPPORT OUR SPONSORSUSATF: The USATF Indoor Track and Field Championships presented by Prevagen are back in New York City from February 28th to March 1st at the Ocean Breeze Athletic Complex in Staten Island. This is where legends don't just race; they punch their ticket to the world stage. The pressure is real, the margins are razor thin, and every athlete is fighting for one thing: a spot on Team USATF at the World Indoor Championships. Grab your tickets now at USATF.org/tickets and experience track and field at its absolute loudest.OLIPOP: A blast from the past, Olipop's Shirley Temple combines smooth vanilla flavor with bright lemon and lime, finished with cherry juice for that nostalgic grenadine-like flavor. One sip of this timeless soda proves some flavors never grow old. Try Shirley Temple and more of Olipop's flavors at DrinkOlipop.com and use code CITIUS25 at checkout to get 25% off your orders.